Evidence map›Paper›PMID 33562739›Full record

ReviewInternational journal of environmental research and public health2021

Graphene-Based Composites as Catalysts for the Degradation of Pharmaceuticals.

Olalekan C Olatunde, Damian C Onwudiwe

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Olalekan C OlatundeMaterial Science Innovation and Modelling (MaSIM) Research Focus Area, Faculty of Natural and Agricultural Sciences, Mafikeng Campus, North-West University, Private Bag X2046, Mmabatho 2735, South Africa.ORCID 0000-0002-8245-0763
Damian C OnwudiweMaterial Science Innovation and Modelling (MaSIM) Research Focus Area, Faculty of Natural and Agricultural Sciences, Mafikeng Campus, North-West University, Private Bag X2046, Mmabatho 2735, South Africa.ORCID 0000-0002-2689-3981

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incessant release of pharmaceuticals into the aquatic environment continues to be a subject of increasing concern. This is because of the growing demand for potable water sources and the potential health hazards which these pollutants pose to aquatic animals and humans. The inability of conventional water treatment systems to remove these compounds creates the need for new treatment systems in order to deal with these class of compounds. This review focuses on advanced oxidation processes that employ graphene-based composites as catalysts for the degradation of pharmaceuticals. These composites have been identified to possess enhanced catalytic activity due to increased surface area and reduced charge carrier recombination. The techniques employed in synthesizing these composites have been explored and five different advanced oxidation processes-direct degradation process, chemical oxidation process, photocatalysis, electrocatalyis processes and sonocatalytic/sono-photocatalytic processes-have been studied in terms of their enhanced catalytic activity. Finally, a comparative analysis of the processes that employ graphene-based composites was done in terms of process efficiency, reaction rate, mineralization efficiency and time required to achieve 90% degradation.

Indexed as

GraphitePharmaceutical PreparationsWater Pollutants, ChemicalWater PurificationCatalysisHumansGraphitePharmaceutical PreparationsWater Pollutants, Chemicaladvanced oxidation processcompositesgraphenepharmaceuticalsreactive radicals

Identifiers

PMID33562739
PMCPMC7914572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.